Abraham F. Quirarte-Brambila, Aarón M. Flores-Aguilar, Elieser Fernández-Vivar
{"title":"墨西哥普埃布拉三级医院转移性肾癌患者与根治性肾切除术后疾病进展患者对分子靶向治疗的反应","authors":"Abraham F. Quirarte-Brambila, Aarón M. Flores-Aguilar, Elieser Fernández-Vivar","doi":"10.24875/bcmu.m23000008","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":431963,"journal":{"name":"Boletín del Colegio Mexicano de Urología","volume":"64 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Respuesta a terapia blanco molecular en pacientes con cáncer renal metastásico vs pacientes con progresión de la enfermedad posterior a nefrectomía radical en un hospital de tercer nivel de Puebla, México\",\"authors\":\"Abraham F. Quirarte-Brambila, Aarón M. Flores-Aguilar, Elieser Fernández-Vivar\",\"doi\":\"10.24875/bcmu.m23000008\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":431963,\"journal\":{\"name\":\"Boletín del Colegio Mexicano de Urología\",\"volume\":\"64 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-05-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Boletín del Colegio Mexicano de Urología\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.24875/bcmu.m23000008\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Boletín del Colegio Mexicano de Urología","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24875/bcmu.m23000008","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Respuesta a terapia blanco molecular en pacientes con cáncer renal metastásico vs pacientes con progresión de la enfermedad posterior a nefrectomía radical en un hospital de tercer nivel de Puebla, México